Abano Healthcare Group Limited provided earnings guidance for the year ending May 31, 2013. For the period, the company expects consolidated revenues to grow to between $207.0 million to $209.0 million, with an Earnings before interest, tax, depreciation and amortisation (EBITDA) of between $27.5 million to $28.5 million and a Net profit after tax (NPAT) of between $2.3 million to $2.8 million. Underlying EBITDA is expected to be between $28.3 million to $29.3 million, resulting in an underlying NPAT of between $4.1 million to $4.6 million.